TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-book ratio
Latest
19.67
↑ 39% above average
Average (9y)
14.19
Historical baseline
Range
High:27.34
Low:5.36
CAGR
+15.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 19.67 | +30.2% |
| 2023 | 15.11 | -44.8% |
| 2022 | 27.34 | +158.1% |
| 2021 | 10.59 | -8.3% |
| 2020 | 11.55 | -54.5% |
| 2019 | 25.40 | +97.3% |
| 2018 | 12.87 | +69.4% |
| 2017 | 7.60 | +19.5% |
| 2016 | 6.36 | +18.6% |
| 2015 | 5.36 | - |